Skip to main content
No.1 Press Release Service in Korea
Search
Search
Login
Create Account
Services
Contact Us
News
Services
About Us
Contact Us
Korean
News
All News
News by Region
Korea
Overseas
News by Industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Services
Why Korea Newswire?
How We Distribute
Services & Pricing
Basic
Standard
Premium
Global
Translation
Press Release Network in Korea
Korean Language
About Us
News
Services
Contact Us
Search
Cancel
Search
Submit Press Release
Latest News
News by Region
Korea
World
News by Industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Health News Releases
Today April 10
September 12, 2017 15:00
Safety and efficacy results from the INJOURNEY™ trial investigating OFEV® (nintedanib) with add-on pirfenidone provide new data to support nintedanib’s key role in IPF
Results from the INJOURNEY™ trial, investigating the use of nintedanib in combination with pirfenidone in treating idiopathic pulmonary fibrosis (IPF), have just been published in the American Journal
September 08, 2017 10:26
Boehringer Ingelheim and Gubra collaborate to develop next generation obesity treatments
Boehringer Ingelheim and Gubra announce a collaboration and license agreement for the development of novel peptide compounds to treat obesity. The collaboration will bring together Gubra’s expertise i
September 07, 2017 17:40
LAC-Shield™, Morinaga Milk's New “Immunogenics” Ingredient, Offers Manufacturers Clinically Tested Immune Benefits and Shelf Stability
Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, today announced that its recently launched “Immunogenics” ingredient LAC-Shield will now be marketed overseas.
September 06, 2017 13:30
Study Evaluates Performance of Masimo iSpO2® Rx Smart Device-Paired Pulse Oximeter in Screening Newborns for Critical Congenital Heart Disease
Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers in Maastricht, The Netherlands evaluated the performance of Masimo iSpO2® Rx in screening newborns
September 04, 2017 17:22
Beautiful Korea Co., Ltd. to enter overseas market with hyaluronic acid (HA) Ammi filler for anti-aging
Beautiful Korea Co., Ltd. (CEO:Byeong Ook Seung) received great praise from abroad for Ammi filler, which was launched in October 2016 and has since been distinguished as a representative hyaluronic a
August 31, 2017 10:40
GN Hearing Launches ReSound ENZO 3D™ and Beltone Boost Max™ - Bringing its New Hearing Care Experience to People with Severe to Profound Hearing Loss
Today, GN Hearing announced the launch of ReSound ENZO 3D™, and the corresponding Beltone Boost Max™, which brings the renowned benefits of ReSound LiNX 3D™ and Beltone Trust™ to people with severe to
August 29, 2017 17:40
Boehringer Ingelheim initiates Phase IIa study of compound acquired from Pharmaxis in debilitating liver disease NASH
Boehringer Ingelheim and pharmaceutical company Pharmaxis (ASX: PXS) announce that Boehringer Ingelheim has initiated a European and North American Phase IIa trial in NASH with BI 1467335 (formerly kn
August 29, 2017 13:55
Study Evaluates Utility of Masimo SpHb® During High-Blood-Loss Oncosurgery
Masimo (NASDAQ:MASI) announced today the findings of a recently published study in which researchers in New Delhi, India evaluated the utility of Masimo SpHb®, noninvasive, continuous hemoglobin measu
August 28, 2017 09:30
Pradaxa® (dabigatran etexilate) dual therapy showed lower rates of major bleeding versus triple therapy with warfarin in atrial fibrillation patients undergoing stent placement
The RE-DUAL PCI™ trial explored anticoagulation with Pradaxa® (dabigatran etexilate) dual therapy without aspirin in non-valvular atrial fibrillation (AF) patients following percutaneous coronary inte
August 25, 2017 16:35
19 Healthcare Organizations in Taiwan Make Commitments Toward Zero Preventable Patient Deaths
The Patient Safety Movement Foundation (PSMF) announced today that 19 hospitals and healthcare organizations in Taiwan have signed a commitment to implement processes to eliminate preventable patient
August 25, 2017 15:55
GRAMINEX L.L.C. Opens New Office in Seoul, Korea, Graminex Korea Co., Ltd.
Graminex® LLC, producer of Graminex® Flower Pollen Extracts™, is pleased to announce the opening of Graminex® Korea Co., Ltd. Sun-Ho Frank Kim, Ph.D. has been appointed Managing Director of the local
August 24, 2017 17:50
Herbalife Nutrition Extends Title Sponsorship for Bali International Triathlon 2017
Global nutrition company, Herbalife has been named as the title sponsor of the Bali International Triathlon for the third consecutive year. Called the Herbalife Bali International Triathlon 2017, the
August 24, 2017 11:55
GN Hearing Announces Availability of Rechargeable Solution for the Recently Launched ReSound LiNX 3D
GN Hearing introduces a rechargeable battery option for the revolutionary ReSound LiNX 3D hearing aids. Available in North America and other major markets from September 1, the rechargeable battery so
August 24, 2017 10:55
Publication of Clinical Data Demonstrating Low Immunogenicity and Excellent Efficacy of Nuwiq® in Previously Untreated Patients
Octapharma is delighted to announce the publication of interim data from the NuProtect study (GENA-05, NCT01712438), the first clinical data on treatment with Nuwiq® in previously untreated patients (
August 22, 2017 15:20
Celularity, Inc., Accelerates Breakthrough Placental Discovery & Therapeutic Platform
Celularity, Inc., a newly formed biotechnology company, today announced its acceleration of cell and tissue regenerative therapies to address unmet medical needs in cancer and chronic and degenerative
August 22, 2017 13:25
Study Investigates Performance of Masimo PVi® As Part of Goal-Directed Fluid Therapy During Laparoscopic Bariatric Surgery
Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Firat University in Turkey evaluated the performance of Masimo PVi®, a noninvasive and continuo
August 21, 2017 16:37
Boehringer Ingelheim: Advancing anticoagulation care with new data at ESC Congress 2017
Boehringer Ingelheim today announced that it will present important new data on the treatment of patients with atrial fibrillation (AF) at the ESC Congress in Barcelona, Spain, 26-30 August 2017. In t
August 14, 2017 17:15
Dubai Health Authority Implements Masimo Patient SafetyNet™
Masimo (NASDAQ:MASI) announced today that the Dubai Health Authority (DHA), the government organization that oversees the healthcare systems of Dubai, is augmenting its current inventory of Masimo equ
August 10, 2017 11:15
noUV Announces Totally New Way to Protect Human Bodies from Harmful UV Rays Using Extract from Ferns
noUV Inc., a health and beauty care supplement company, has created “noUV,” an orally ingestible sunscreen supplement as a totally new way to protect the body from harmful effects of the sun’s ultravi
August 09, 2017 19:00
FDA Allows WIN Consortium to Proceed with Targeted Tri-Therapy Clinical Trial in First Line Treatment of Metastatic Non Small Cell Lung Cancer
WIN Consortium (WIN) received the US Food and Drug Administration (FDA)’s approval to start the clinical investigation of a novel therapeutic approach using a combination of three targeted therapies f
August 08, 2017 14:00
Study Evaluates Performance of Masimo SpHb® in Trauma Patients with Low Hemoglobin Levels
Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Cairo University in Egypt evaluated the performance of Masimo SpHb®, noninvasive, continuous he
August 04, 2017 17:15
Swift Biosciences Announces New Industry-Leading Indexed Adapters for Sequencing Larger Numbers of Samples in a Single Run
Swift Biosciences, a leading provider of innovative library prep solutions for genomic sequencing, today announced the launch of Accel-NGS® 2S Indexed Adapters, a new portfolio of indices that signifi
August 03, 2017 13:45
Takeda Reports 1st Quarter FY2017 Results
Takeda Pharmaceutical Company Limited (TOKYO:4502): Underlying Revenue growth of 6.6% led by Takeda's Growth Drivers · Underlying Revenue grew +6.6% with growth across all regions (U.S. +13.5%,
August 02, 2017 14:55
Graminex L.L.C. Receives NNHPD Health Canada Approval for PollenAid® and Prostanex®
Graminex® LLC, producer of Graminex® Flower Pollen Extracts™, receives Health Canada Approval under the Natural and Non-prescription Health Products Directorate (NNHPD) for its PollenAid® and Prostane
August 01, 2017 13:25
Study Compares Performance of Masimo Acoustic Respiration Rate (RRa®) and Nellcor Plethysmographic Respiration Rate in Volunteers
Masimo (NASDAQ: MASI) announced today that researchers at the Tokyo Women’s Medical University, Department of Anesthesiology, in Japan have published a study investigating the measurement of respirati
«
121
122
123
124
125
»
25 per page
25 per page
50 per page
75 per page
100 per page
Distribute Your News to
KOREA
The largest press release distribution network in Korea
43,000 journalists
7,000 media outlets
345 industry channel
80,000 subscribers
Get Started
Global PR service
Reach Your Target
Audience in 160 Countries
powered by
Get Started
News by region
Korea
Overseas
News by industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Notice